We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02928029
Title Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Pacific Oncology/Hematology Associates Encinitas California 92024 United States Details
Wake Forest Baptist Health Winston-Salem North Carolina 27157 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109-4417 United States Details
National Cancer Center Goyang-si Gyeonggido 410-769 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Hospital Universitari Son Espases Palma de Mallorca Illes Baleares 07120 Spain Details
Hospital Universitario Virgen del Rocío Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field